{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:01:56Z","timestamp":1791223316754,"version":"4.1.0"},"reference-count":31,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Surg"],"published-print":{"date-parts":[[2024,6,1]]},"abstract":"<jats:sec id=\"ab-soi240006-4\"><jats:title>Importance<\/jats:title><jats:p>Higher lymphedema rates after axillary lymph node dissection (ALND) have been found in Black and Hispanic women; however, there is poor correlation between subjective symptoms, quality of life (QOL), and measured lymphedema. Additionally, racial and ethnic differences in QOL have been understudied.<\/jats:p><\/jats:sec><jats:sec id=\"ab-soi240006-5\"><jats:title>Objective<\/jats:title><jats:p>To evaluate the association of race and ethnicity with long-term QOL in patients with breast cancer treated with ALND.<\/jats:p><\/jats:sec><jats:sec id=\"ab-soi240006-6\"><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>This cohort study enrolled women aged 18 years and older with breast cancer who underwent unilateral ALND at a tertiary cancer center between November 2016 and March 2020. Preoperatively and at 6-month intervals, arm volume was measured by perometer and QOL was assessed using the Upper Limb Lymphedema-27 (ULL-27) questionnaire, a validated tool for assessing lymphedema that evaluates how arm symptoms affect physical, psychological, and social functioning. Data were analyzed from November 2016 to October 2023.<\/jats:p><\/jats:sec><jats:sec id=\"ab-soi240006-7\"><jats:title>Exposures<\/jats:title><jats:p>Breast surgery and unilateral ALND in the primary setting or after sentinel lymph node biopsy.<\/jats:p><\/jats:sec><jats:sec id=\"ab-soi240006-8\"><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>Scores in each domain of the ULL-27 were compared by race and ethnicity. Factors impacting QOL were identified using multivariable regression analyses.<\/jats:p><\/jats:sec><jats:sec id=\"ab-soi240006-9\"><jats:title>Results<\/jats:title><jats:p>The study included 281 women (median [IQR] age, 48 [41-58] years) with breast cancer who underwent unilateral ALND and had at least 6 months of follow-up. Of these, 30 patients (11%) self-identified as Asian individuals, 57 (20%) as Black individuals, 23 (8%) as Hispanic individuals, and 162 (58%) as White individuals; 9 individuals (3%) who did not identify as part of a particular group or who were missing race and ethnicity data were categorized as having unknown race and ethnicity. Median (IQR) follow-up was 2.97 (1.96-3.67) years. The overall 2-year lymphedema rate was 20% and was higher among Black (31%) and Hispanic (27%) women compared with Asian (15%) and White (17%) women (<jats:italic>P<\/jats:italic>\u2009=\u2009.04). Subjective arm swelling was more common among Asian (57%), Black (70%), and Hispanic (87%) women than White (44%) women (<jats:italic>P<\/jats:italic>\u2009&amp;amp;lt;\u2009.001), and lower physical QOL scores were reported by racial and ethnic minority women at nearly every follow-up. For example, at 24 months, median QOL scores were 87, 79, and 80 for Asian, Black, and Hispanic women compared with 92 for White women (<jats:italic>P<\/jats:italic>\u2009=\u2009.003). On multivariable analysis, Asian race (\u03b2\u2009=\u2009\u20135.7; 95% CI, \u22129.5 to \u22121.8), Hispanic ethnicity (\u03b2\u2009=\u2009\u201310.0; 95% CI, \u221215.0 to \u22125.2), and having Medicaid (\u03b2\u2009=\u2009\u22125.4; 95% CI, \u22129.2 to \u22121.7) or Medicare insurance (\u03b2\u2009=\u2009\u22126.9; 95% CI, \u221210.0 to \u22123.4) were independently associated with worse physical QOL (all <jats:italic>P<\/jats:italic>\u2009&amp;amp;lt;\u2009.001).<\/jats:p><\/jats:sec><jats:sec id=\"ab-soi240006-10\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>Findings of this cohort study suggest that Asian, Black, and Hispanic women experience more subjective arm swelling after unilateral ALND for breast cancer compared with White women. Black and Hispanic women had higher rates of objective lymphedema than their White counterparts. Both minority status and public medical insurance were associated with worse physical QOL. Understanding disparities in QOL after ALND is an unmet need and may enable targeted interventions to improve QOL for these patients.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamasurg.2024.0118","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T15:32:57Z","timestamp":1711553577000},"page":"668","source":"Crossref","is-referenced-by-count":16,"title":["Quality of Life After Axillary Lymph Node Dissection Among Racial and Ethnic Minority Women"],"prefix":"10.1001","volume":"159","author":[{"given":"Danielle R.","family":"Heller","sequence":"first","affiliation":[{"name":"Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bayley","family":"Axelrod","sequence":"additional","affiliation":[{"name":"Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varadan","family":"Sevilimedu","sequence":"additional","affiliation":[{"name":"Biostatistics Service, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Morrow","sequence":"additional","affiliation":[{"name":"Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babak J.","family":"Mehrara","sequence":"additional","affiliation":[{"name":"Plastic and Reconstructive Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea V.","family":"Barrio","sequence":"additional","affiliation":[{"name":"Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"2","key":"soi240006r1","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/jso.v102:2","article-title":"Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection.","volume":"102","author":"Ashikaga","year":"2010","journal-title":"J Surg Oncol"},{"issue":"4","key":"soi240006r2","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1097\/SLA.0000000000005671","article-title":"Impact of axillary lymph node dissection and sentinel lymph node biopsy on upper limb morbidity in breast cancer patients: a systematic review and meta-analysis.","volume":"277","author":"Che Bakri","year":"2023","journal-title":"Ann Surg"},{"issue":"6","key":"soi240006r3","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/S1470-2045(13)70076-7","article-title":"Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis.","volume":"14","author":"DiSipio","year":"2013","journal-title":"Lancet Oncol"},{"issue":"5","key":"soi240006r4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0096748","article-title":"Treatment related impairments in arm and shoulder in patients with breast cancer: a systematic review.","volume":"9","author":"Hidding","year":"2014","journal-title":"PLoS One"},{"issue":"8","key":"soi240006r5","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1001\/jamaoncol.2022.1628","article-title":"Risk factors and racial and ethnic disparities in patients with breast cancer\u2013related lymphedema.","volume":"8","author":"Montagna","year":"2022","journal-title":"JAMA Oncol"},{"issue":"20","key":"soi240006r6","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1200\/JCO.19.02896","article-title":"Breast cancer\u2013related lymphedema: risk factors, screening, management, and the impact of locoregional treatment.","volume":"38","author":"McLaughlin","year":"2020","journal-title":"J Clin Oncol"},{"key":"soi240006r7","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1186\/s40064-016-2300-8","article-title":"Worse and worse off: the impact of lymphedema on work and career after breast cancer.","volume":"5","author":"Boyages","year":"2016","journal-title":"Springerplus"},{"issue":"2","key":"soi240006r8","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1089\/lrb.2017.0046","article-title":"Quality of life questionnaires in breast cancer\u2013related lymphedema patients: review of the literature.","volume":"16","author":"Cornelissen","year":"2018","journal-title":"Lymphat Res Biol"},{"issue":"9","key":"soi240006r9","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1002\/pon.v23.9","article-title":"The psychosocial impact of lymphedema-related distress among breast cancer survivors in the WHEL Study.","volume":"23","author":"Dominick","year":"2014","journal-title":"Psychooncology"},{"issue":"11","key":"soi240006r10","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1007\/s00520-005-0810-y","article-title":"Quality of life and a symptom cluster associated with breast cancer treatment\u2013related lymphedema.","volume":"13","author":"Ridner","year":"2005","journal-title":"Support Care Cancer"},{"key":"soi240006r11","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-022-11623-z","article-title":"Longitudinal prospective evaluation of quality of life after axillary lymph node dissection.","author":"Zhang","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"soi240006r12","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00520-018-4334-7","article-title":"Lymphedema symptoms and limb measurement changes in breast cancer survivors treated with neoadjuvant chemotherapy and axillary dissection: results of American College of Surgeons Oncology Group (ACOSOG) Z1071 (Alliance) substudy.","volume":"27","author":"Armer","year":"2019","journal-title":"Support Care Cancer"},{"issue":"1","key":"soi240006r13","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s10549-016-3913-x","article-title":"Race\/ethnicity, genetic ancestry, and breast cancer\u2013related lymphedema in the Pathways Study.","volume":"159","author":"Kwan","year":"2016","journal-title":"Breast Cancer Res Treat"},{"issue":"23","key":"soi240006r14","doi-asserted-by":"publisher","first-page":"4119","DOI":"10.1002\/cncr.v128.23","article-title":"Burden of lymphedema in long-term breast cancer survivors by race and age.","volume":"128","author":"Ren","year":"2022","journal-title":"Cancer"},{"key":"soi240006r15","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S1098-3015(11)71503-0","article-title":"A specific quality of life scale in upper limb lymphedema: the ULL-27 questionnaire.","volume":"35","author":"Launois","year":"2002","journal-title":"Lymphology"},{"issue":"1","key":"soi240006r17","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ijrobp.2018.08.036","article-title":"Timing of lymphedema after treatment for breast cancer: when are patients most at risk?","volume":"103","author":"McDuff","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"soi240006r18","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.ijrobp.2010.01.001","article-title":"Standardized method for quantification of developing lymphedema in patients treated for breast cancer.","volume":"79","author":"Ancukiewicz","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"soi240006r19","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/cncr.v127.2","article-title":"Health-related quality of life outcomes for the LEAP study-CALGB 70305 (Alliance): a lymphedema prevention intervention trial for newly diagnosed breast cancer patients.","volume":"127","author":"Naughton","year":"2021","journal-title":"Cancer"},{"issue":"32","key":"soi240006r20","doi-asserted-by":"publisher","first-page":"5213","DOI":"10.1200\/JCO.2008.16.3725","article-title":"Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements.","volume":"26","author":"McLaughlin","year":"2008","journal-title":"J Clin Oncol"},{"issue":"2","key":"soi240006r21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1158\/1055-9965.EPI-22-0692","article-title":"Race differences in patient-reported symptoms during chemotherapy among women with early-stage hormone receptor\u2013positive breast cancer.","volume":"32","author":"Hu","year":"2023","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"soi240006r22","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1158\/1055-9965.EPI-22-1111","article-title":"Racial differences in breast cancer therapeutic toxicity: implications for practice.","volume":"32","author":"Rosenzweig","year":"2023","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"soi240006r23","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.ijrobp.2015.05.049","article-title":"A preliminary study on racial differences in HMOX1, NFE2L2, and TGF\u00df1 gene polymorphisms and radiation-induced late normal tissue toxicity.","volume":"93","author":"Alam","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"soi240006r24","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1097\/00130404-200307000-00014","article-title":"Clinical outcome and cosmesis in African-American patients treated with conservative surgery and radiation therapy.","volume":"9","author":"Tuamokumo","year":"2003","journal-title":"Cancer J"},{"issue":"1","key":"soi240006r25","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s11764-012-0247-5","article-title":"Quality of life among breast cancer patients with lymphedema: a systematic review of patient-reported outcome instruments and outcomes.","volume":"7","author":"Pusic","year":"2013","journal-title":"J Cancer Surviv"},{"key":"soi240006r26","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2021-066542","article-title":"Exercise versus usual care after non-reconstructive breast cancer surgery (UK PROSPER): multicentre randomised controlled trial and economic evaluation.","volume":"375","author":"Bruce","year":"2021","journal-title":"BMJ"},{"issue":"18","key":"soi240006r27","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1200\/JCO.21.02567","article-title":"Prophylactic use of compression sleeves reduces the incidence of arm swelling in women at high risk of breast cancer\u2013related lymphedema: a randomized controlled trial.","volume":"40","author":"Paramanandam","year":"2022","journal-title":"J Clin Oncol"},{"issue":"3","key":"soi240006r28","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1001\/jamaoncol.2019.5672","article-title":"Association of insurance status and racial disparities with the detection of early-stage breast cancer.","volume":"6","author":"Ko","year":"2020","journal-title":"JAMA Oncol"},{"issue":"5","key":"soi240006r29","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1056\/NEJM199307293290507","article-title":"The relation between health insurance coverage and clinical outcomes among women with breast cancer.","volume":"329","author":"Ayanian","year":"1993","journal-title":"N Engl J Med"},{"issue":"6","key":"soi240006r30","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/s00520-023-07800-9","article-title":"Financial toxicity experienced by patients with breast cancer\u2013related lymphedema: a systematic review.","volume":"31","author":"Bian","year":"2023","journal-title":"Support Care Cancer"},{"issue":"9","key":"soi240006r31","doi-asserted-by":"publisher","first-page":"5637","DOI":"10.1245\/s10434-023-13431-5","article-title":"Ancillary treatment referrals and visits after breast cancer surgery in a sociodemographically diverse population.","volume":"30","author":"Chan","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"soi240006r16","unstructured":"Memorial Sloan Kettering Cancer Center. A prospective surveillance program for assessment and treatment of breast cancer\u2013related lymphedema after axillary lymph node dissection. Accessed December 18, 2023. https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT02743858?term=02743858&draw=2&rank=1."}],"container-title":["JAMA Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/articlepdf\/2816987\/jamasurgery_heller_2024_oi_240006_1718026168.50786.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T15:02:03Z","timestamp":1718204523000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/fullarticle\/2816987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,1]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamasurg.2024.0118","relation":{},"ISSN":["2168-6254"],"issn-type":[{"value":"2168-6254","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,1]]}}}